USANA Health Sciences (USNA) Announces Dismissal of Class Action Suit
More News related to USNA
- USANA Health Sciences Launches Vitamin D Supplement
- USANA Supported Clinical Study Demonstrates Improved Bone Health in Girls
- Analyst Defends USANA (USNA) as Shares Plunge: Upgrades to Buy
- Morning Movers 10/28: CSBC, QTM, ANIK, RSYS, PEET, WSII Higher; CALC, KSP, PSYS, VCLK, VPHM, GT Lower
- USANA Health Sciences (USNA) Posts Q3 EPS of $0.51, Beats By 3c; Guides FY09
More News related to Corporate News
- Regent Communications (RGCI) Receives Delisting Notification From NASDAQ
- Emclaire Financial (EMCF) to Withdraw $20M Common Offerin; Cites Unfavorable Market Conditions
- Swine Flu Cases Decline to Lowest Level in 2+ Months
- Tri-Valley Corp. (TIV) Will Stay on NYSE AMEX, Deficiency Resolved
- Phoenix Footwear (PXG) Enters into $4.5M Secured Revolving Credit Facility
USANA Health Sciences, Inc. (NASDAQ: USNA) announced that a California State court has dismissed the distributor class action suit, Johnson v. USANA, filed in 2007 against the company and certain of its officers, distributors and directors. The Plaintiffs agreed to request that the court dismiss the case with prejudice after plaintiffs reviewed recent evidence and determined there was no longer any merit to maintaining a class action lawsuit.
“We are pleased that the court approved this motion to dismiss,” said Dave Wentz, chief executive officer, USANA Health Sciences, Inc. “We will continue to move forward without further distraction or expense.”
USANA Health Sciences, Inc. (USANA) develops and manufactures science-based nutritional and personal care products. [SM]
Related Categories
Corporate NewsStocks Mentioned
+0.52Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
